• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物米托蒽醌和氨茴环素及其相关结构与脱氧核糖核酸的结合特性。

Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids.

作者信息

Lown J W, Morgan A R, Yen S F, Wang Y H, Wilson W D

出版信息

Biochemistry. 1985 Jul 16;24(15):4028-35. doi: 10.1021/bi00336a034.

DOI:10.1021/bi00336a034
PMID:4052381
Abstract

The binding constants for interaction of the anticancer agents mitoxantrone and ametantrone and several congeners with calf thymus DNA and the effects of ionic strength changes have been determined spectrophotometrically. The agents show a preference for certain sequences, particularly those with GC base pairs, and the magnitude of the specificity depends on the specific substituents on the anthraquinone ring system. The binding constant for mitoxantrone with calf thymus DNA in 0.1 M Na+, pH 7, is approximately 6 X 10(6) M-1, and the rate constant for the sodium dodecyl sulfate driven dissociation of mitoxantrone from its calf thymus DNA complex under the same solution conditions and 20 degrees C was determined to be 1.3 s-1. The unwinding angle of mitoxantrone determined independently by viscosity measurements and by a novel assay employing calf thymus topoisomerase shows excellent agreement for a value of 17.5 degrees. The viscosity increase of sonicated calf thymus DNA varies considerably with the substituent on the anthraquinone ring system. Binding studies employing T4 and phi w-14 DNAs in which the major groove is occluded and the reverse experiment with anthramycin-treated calf thymus DNA indicate at least part of the mitoxantrone molecule may lie in the minor groove.

摘要

已通过分光光度法测定了抗癌药物米托蒽醌、氨茴环素及其几种同系物与小牛胸腺DNA相互作用的结合常数以及离子强度变化的影响。这些药物对某些序列有偏好,特别是那些含有GC碱基对的序列,特异性的程度取决于蒽醌环系统上的特定取代基。在0.1 M Na⁺、pH 7条件下,米托蒽醌与小牛胸腺DNA的结合常数约为6×10⁶ M⁻¹,在相同溶液条件和20℃下,十二烷基硫酸钠驱动米托蒽醌从小牛胸腺DNA复合物中解离的速率常数测定为1.3 s⁻¹。通过粘度测量和采用小牛胸腺拓扑异构酶的新方法独立测定的米托蒽醌解旋角,对于17.5°的值显示出极好的一致性。超声处理的小牛胸腺DNA的粘度增加随蒽醌环系统上的取代基有很大变化。使用T4和ϕw - 14 DNA(其中大沟被封闭)进行的结合研究以及用氨茴霉素处理小牛胸腺DNA的反向实验表明,米托蒽醌分子的至少一部分可能位于小沟中。

相似文献

1
Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids.抗癌药物米托蒽醌和氨茴环素及其相关结构与脱氧核糖核酸的结合特性。
Biochemistry. 1985 Jul 16;24(15):4028-35. doi: 10.1021/bi00336a034.
2
Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly[d(G-C)].poly[d(G-C)], and poly[d(A-T)].poly[d(A-T)].蒽醌类抗癌药物与小牛胸腺DNA、聚[d(G-C)]·聚[d(G-C)]以及聚[d(A-T)]·聚[d(A-T)]相互作用的停流动力学分析
Biochemistry. 1986 Oct 7;25(20):5933-40. doi: 10.1021/bi00368a015.
3
Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization.
Mol Pharmacol. 1988 Mar;33(3):265-71.
4
The antitumor agent mitoxantrone binds cooperatively to DNA: evidence for heterogeneity in DNA conformation.抗肿瘤药物米托蒽醌与DNA协同结合:DNA构象异质性的证据。
Biochemistry. 1986 Mar 11;25(5):1002-8. doi: 10.1021/bi00353a008.
5
Substituent position dictates the intercalative DNA-binding mode for anthracene-9,10-dione antitumor drugs.
Biochemistry. 1992 Nov 24;31(46):11632-40. doi: 10.1021/bi00161a050.
6
Interaction between a 3-nitrobenzothiazolo (3,2-a) quinolinium antitumour drug and deoxyribonucleic acid.
Biochem Pharmacol. 1983 Jul 1;32(13):2089-94. doi: 10.1016/0006-2952(83)90431-8.
7
Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA.光谱研究抗癌药物米托蒽醌与小牛胸腺 DNA 相互作用的影响。
J Photochem Photobiol B. 2013 Mar 5;120:177-82. doi: 10.1016/j.jphotobiol.2012.11.001. Epub 2012 Dec 6.
8
Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity.米托蒽醌、氨甲蒽醌及其类似物与DNA结合的动力学:与结合模式及抗肿瘤活性的关系。
Anticancer Drug Des. 1990 May;5(2):189-200.
9
32P-postlabelling analysis of adducts formed by mitoxantrone and ametantrone with DNA and homopolydeoxyribonucleotides after enzymatic activation.米托蒽醌和氨茴环素经酶促活化后与DNA及同聚脱氧核糖核苷酸形成的加合物的32P后标记分析。
Chem Biol Interact. 1995 Nov 17;98(2):153-66. doi: 10.1016/0009-2797(95)03643-1.
10
Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.通过电子显微镜研究抗肿瘤药物米托蒽醌和双胺苯吖啶与脱氧核糖核酸的相互作用。
Mol Pharmacol. 1984 Jan;25(1):178-84.

引用本文的文献

1
Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery.特定抗生素的药物再利用:癌症药物发现中的一种新兴方法。
ACS Omega. 2024 Jun 13;9(25):26762-26779. doi: 10.1021/acsomega.4c00617. eCollection 2024 Jun 25.
2
Interaction of mitoxantrone with abasic sites - DNA strand cleavage and inhibition of apurinic/apyrimidinic endonuclease 1, APE1.米托蒽醌与无碱基位点的相互作用- DNA 链断裂和嘌呤/嘧啶内切核酸酶 1(APE1)的抑制。
DNA Repair (Amst). 2024 Jan;133:103606. doi: 10.1016/j.dnarep.2023.103606. Epub 2023 Nov 20.
3
and A Genes Comprising G-Quadruplex as Promising Therapeutic Targets against : Molecular Recognition by Mitoxantrone Suppresses Replication and Gene Regulation.
和 A 基因组成的 G-四链体作为有前途的治疗靶点针对:米托蒽醌的分子识别抑制复制和基因调控。
Genes (Basel). 2023 Apr 26;14(5):978. doi: 10.3390/genes14050978.
4
Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers.利用磁镊技术研究抗癌化疗药物米托蒽醌与 DNA 的结合机制。
J Nanobiotechnology. 2018 Jul 13;16(1):56. doi: 10.1186/s12951-018-0381-y.
5
Dual Function of Gold Nanoparticles in Synergism with Mitoxantrone and Microwave Hyperthermia Against Melanoma Cells.金纳米粒子与米托蒽醌及微波热疗协同作用对黑色素瘤细胞的双重功能
Asian Pac J Cancer Prev. 2017 Nov 26;18(11):2911-2917. doi: 10.22034/APJCP.2017.18.11.2911.
6
Mitoxantrone-Surfactant Interactions: A Physicochemical Overview.米托蒽醌与表面活性剂的相互作用:物理化学概述
Molecules. 2016 Oct 13;21(10):1356. doi: 10.3390/molecules21101356.
7
Tetrahydroanthraquinone Derivative (±)-4-Deoxyaustrocortilutein Induces Cell Cycle Arrest and Apoptosis in Melanoma Cells via Upregulation of p21 and p53 and Downregulation of NF-kappaB.四氢蒽醌衍生物(±)-4-脱氧澳柯替菌素通过上调p21和p53以及下调核因子κB诱导黑色素瘤细胞的细胞周期阻滞和凋亡。
J Cancer. 2016 Mar 12;7(5):555-68. doi: 10.7150/jca.13614. eCollection 2016.
8
The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: Selective release of histone proteins.米托蒽醌作为一种抗癌药物对肝细胞核和染色质的影响:组蛋白的选择性释放。
Indian J Pharmacol. 2011 Apr;43(2):187-91. doi: 10.4103/0253-7613.77362.
9
Evaluation of molecular descriptors for antitumor drugs with respect to noncovalent binding to DNA and antiproliferative activity.关于抗肿瘤药物与DNA非共价结合及抗增殖活性的分子描述符评估。
BMC Pharmacol. 2009 Sep 16;9:11. doi: 10.1186/1471-2210-9-11.
10
Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins.抗癌药物米托蒽醌与染色质、DNA和组蛋白的结合亲和力研究。
J Biomed Sci. 2009 Mar 11;16(1):31. doi: 10.1186/1423-0127-16-31.